Gene Query: MUTYH

Dataset Description Geneva Score
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.83
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 7.04
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.81
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.75
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 6.01
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.09
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 4.9
RNAseq analysis of ESRP regulated splicing events in prostate cancer 4.34
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.13
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.94
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.67
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.65
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.45
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.39
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.36
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.36
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.26
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.19
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.1
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.05
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.05
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.03
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.03
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.01
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.01
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.92
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.91
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.78
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.75
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.74
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.74
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.71
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.71
METTL3 promotes translation in human cancer cells 2.68
RNAseq Study in CC-671 Treated Cal-51 Cells 2.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 2.61
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 2.58
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.56
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.51
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.46
Differential gene expression of human melanoma cells [RNA-seq] 2.46
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.46
High-efficiency RNA-based reprogramming of human primary fibroblasts 2.46
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 2.45
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.4
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.4
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.38
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.37
Gene expression in GBM with Cav3.2 inhibition 2.37
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.36
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.35
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.34
Impact of dieldrin on transcription in Jurkat T cells 2.33
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.3
HNRNPM-regulated splicing dependencies in prostate cancer 2.3
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.29
Lysine benzoylation is a novel histone mark [RNA-seq] 2.25
Lysine benzoylation is a novel histone mark 2.25
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.22
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 2.19
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.16
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.14
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.14
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.13
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 2.11
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.09
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 2.09
Gene expression signatures of innate lymphoid cells from human blood 2.06
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.05
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.01
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 2.01
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 1.97
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.97
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.96
Modulation of nonsense-mediated decay by rapamycin 1.96
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.95
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.94
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.93
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.92
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.92
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.92
Biological effect of chronic mistranslation in mammalian cells 1.91
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.91
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 1.91
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 1.88
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.88
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.85
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.85
RNA-Seq from human ILC transitional populations 1.85
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 1.83
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.81
RNA-seq of SCLC PDX models treated with EP 1.77
Transcriptome analysis of U87 cells upon LINC00152 knockdown 1.72
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 1.72
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 1.72
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.71
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.69
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.69
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.68
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.68
U1 snRNP telescripting regulates size-function stratified human genome 1.68
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.67
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.67
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.66
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.66
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 1.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.65
T47D RNA-seq and ChrRNA-seq data 1.65
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 1.65
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.65
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.64
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.62
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 1.61
High-throughput sequencing of pluripotent cells 1.6
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.59
RNA-seq analysis of RALD iPSCs after in vitro differentiation 1.56
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.56
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 1.55
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 1.55
CDK4/6 inhibitor resistance in prostate cancer 1.55
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.54
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.54
CROP-Seq in Primary Human T Cells 1.54
Induced DNA demethylation, genome instability and transcription 1.53
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.53
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 1.53
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.52
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 1.51
iPSC-Derived Cholangiocytes 1.5
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.47
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 1.47
Bone marrow derived human B cells [normal proB] 1.46
Proliferation-correlated expression 1.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.45
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.45
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 1.44
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.44
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.43
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.42
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.42
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.4
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.4
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.4
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.39
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.38
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.38
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.38
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.38
U2AF1 mutations alter splice site recognition in hematological malignancies 1.36
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.35
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.35
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 1.35
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 1.35
Single-Cell Genotyping of Transcriptomes 1.34
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.34
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 1.33
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.33
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.32
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.31
Survival of pancreatic cancer cells lacking KRAS function 1.31
Downregulation of DDX5/DDX17 and REST 1.31
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.31
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.3
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.3
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.28
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.28
Global analysis of enhancer targets: Mosaic-seq 1.27
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 1.26
Global gene expression profile of dasatinib-resistant RCH-ACV cells 1.26
Landscape and variation of RNA secondary structure across the human transcriptome 1.25
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.25
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.25
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.24
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.24
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 1.23
Regulation of protein translation during mitosis 1.23
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.22
Gene expressions of H9s in different culture systems 1.22
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.21
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.21
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.21
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.21
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 1.2
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.2
Clinker: visualizing fusion genes detected in RNA-seq data 1.2
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.19
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.19
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.19
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 1.19
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 1.19
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.18
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.18
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.18
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.17
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.16
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 1.15
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.13
RNA-seq of tumor cells following angiopellosis extravasation 1.12
Discovering human diabetes-risk gene function with genetics and physiological assays 1.12
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 1.12
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.11
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 1.1
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.07
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.07
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.06
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.06
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.06
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.05
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.05
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.05
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.03
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.03
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.02
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.02
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.01
Transcriptome analysis of SKI knock-out in HL60 cells 1.01
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.01
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.01
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.0
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 0.99
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 0.99
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.99
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.99
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.98
MeRIP-seq for heat shock in B-cell lymphoma cells 0.98
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.97
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.97
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.96
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 0.96
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.96
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.96
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.96
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 0.96
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 0.96
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.96
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.96
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.95
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 0.95
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.95
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 0.94
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.94
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.93
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.93
Co-regulation of splicing by Rbfox1 and hnRNP M 0.92
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.92
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 0.92
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.9
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.9
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.9
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.9
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.89
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.89
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.89
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.89
Dysregulated immune system networks in war veterans with PTSD 0.88
scRNASeq analysis of cycling cardiomyocytes 0.88
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.88
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.88
KLF6-dependent transcription in renal cancer cells 0.86
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.85
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.85
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.82
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.82
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.81
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.81
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.81
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.81
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.79
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.79
Ectoderm specification of H1 human embryonic stem cells 0.79
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 0.79
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.77
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.76
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.76
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.76
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.76
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.76
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.75
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.74
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.74
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.73
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.73
Glioblastoma stem cells infected by ZIKA virus 0.72
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.72
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.72
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.72
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.71
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.71
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.71
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.71
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.71
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.69
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.69
Function and hormonal regulation of GATA3 in human first trimester placentation 0.68
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.68
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.68
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.68
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.68
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.67
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.67
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.66
Identification of global XBP1s target gene expression in human prostate cancer cells 0.65
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.65
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 0.65
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.65
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.65
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.65
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.64
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.64
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.64
FGF2 regulation of gene expression in stable inducible Neurons 0.64
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.64
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 0.63
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.63
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.63
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 0.62
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.62
Role of FGFR1 in neuronal devlopment 0.62
H1609088 Human RNA-Sequencing 0.62
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.61
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.61
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.61
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.61
Identification of renal resident macrophages across species [C1] 0.6
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.6
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.6
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.59
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.59
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.59
ML29755 RNA-seq data 0.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.58
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.58
Transciptomic profiling of human fetal lung samples 0.58
RNA-seq of naive and primed ES cells (NHSM) 0.58
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.57
Gene expression analysis upon mtDNA depletion 0.57
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.57
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.57
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.57
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.56
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 0.56
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.54
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.54
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.54
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.53
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.53
RNAseq of T-ALL upon long non coding rna purturbation 0.53
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 0.53
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 0.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.51
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.51
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.51
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.5
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.5
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.5
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.5
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.5
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.5
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.5
naive T cell heterogeneity after neonatal thymectomy 0.49
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.49
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.48
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.48
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.46
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 0.46
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.46
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.46
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.46
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.46
The DPYSL2 gene connects mTOR and schizophrenia 0.45
Next Generation Sequencing of human SMA and healthy control Motor Neurons 0.45
Identification of renal resident macrophages across species 0.44
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.44
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.43
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.42
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.42
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.42
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.41
quanTIseq: quantifying immune contexture of human tumors 0.41
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 0.4
RNA-seq of resting and activated CD4+ T cells +-JQ1 0.4
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.39
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.39
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.39
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.39
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.39
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.38
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.38
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.38
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 0.38
RNAseq analysis of ruxolitinib treated breast cancers 0.37
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.37
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.37
Measure transcript integrity using RNA-seq data 0.37
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.36
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.36
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.35
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.35
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.35
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.35
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.35
Transcriptome sequencing of K-562 cells 0.34
Analyses of T-ALL (COG study) 0.34
RNA sequencing of T-ALL (COG study) 0.34
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 0.33
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.33
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.33
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.33
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.33
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.32
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.32
Expression analysis of the TAF1 syndrome 0.32
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.32
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.31
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.28
MARS Seq data from human cortical organoids 0.28
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.27
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.27
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.26
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.26
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.26
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.26
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.25
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.24
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.24
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.22
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.22
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.21
Oncogenic roles of ARID5B in T-ALL 0.2
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.2
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.2
K562 polyA RNA-Seq 0.19
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.18
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.18
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.18
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.17
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.17
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.16
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.16
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.15
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.15
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.15
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.15
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.14
Preclinical model of obesity and ER-positive breast cancer 0.14
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.14
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.13
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.13
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.13
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.12
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.12
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.12
The transcriptome and chromatin accessbility landscape of mammalian germline 0.12
SNHG5 siRNA knock down in HCT116 cells 0.12
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.12
RNA-seq data 0.12
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.11
Epigenomic conservation of transposable element silencing 0.11
Epigenomic conservation of transposable element silencing [RNA-seq] 0.11
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.1
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.1
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.1
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.1
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.09
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.09
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.09
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.09
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.08
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.08
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.07
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.07
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.07
Transcriptome-wide modulation of splicing by the exon junction complex 0.07
MHC Transcriptomic landscape at haplotype-specific resolution 0.07
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.07
Gene expression changes due to PARP knockdown in human cells 0.06
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.06
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.06
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.04
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.04
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.04
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.04
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.04
The role of m6A/m-RNA methylation in stress response regulation 0.04
BACH2 in human plasma cell fate decision 0.04
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.04
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.04
Gene expression profiling of leukemia cells following asparagine depletion 0.03
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.02
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.02
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.02
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.01
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.01
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation